Healthcare
With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.
Contact advisor![](https://www.oaklins.com/uploads/sites/8/2022/03/HEALTHCARE-detail.2022.jpg)
Sopharma Group has acquired two pharmaceutical products in Poland
Sopharma Group has acquired Coffepirine and Kopiryna, two highly recognized medicines to treat headache. The acquisition will further expand the market presence of Sopharma Group in the Polish market and support the promising potential of the two pharmaceutical drugs.
Learn moreSAT Health expands its outpatient care by acquiring Blocks Medical Center
Blocks Health and Social Care has sold Blocks Medical Center Mladost to SAT Health, a private equity-backed healthcare data analytics and outpatient care provider.
Learn morePia Mater, a social services firm, has been acquired by SAT Heath
The founders of Pia Mater Ltd. have sold the company to SAT Health.
Learn more![](/api/deal-client-photo/109552/deal-client-photo.jpeg)
Jan-Frederik Kolthoff
Founder and CEO, move UP Gesellschaft für Gesundheitsmanagement mbH
Read more![](/api/deal-client-logo/109552/deal-client-logo.png)
Reshaping industries: M&A highlights and strategic vision
QUARTERLY M&A ACTIVITY: The second quarter of 2024 marked a dynamic period for Oaklins with 62 closed transactions. This activity underscores the adaptability of various industries to evolving market conditions and strategic imperatives.
Learn more![](https://d21buns5ku92am.cloudfront.net/68798/images/544504-q2%202024%20hero-0fafbe-large-1719927574.jpg)
Talk to our local advisors
Meet our global industry specialists
Michael S. Goldman
Oaklins TM Capital